GALT Archived Articles
Galectin Therapeutics (GALT): The Galectin-3 Pioneer Fighting Liver Disease and Cancer
Published on March 13, 2025
Galectin Therapeutics (NASDAQ:GALT) - Targeting Galectin-3 to Address Unmet Medical Needs
Published on November 28, 2024
Galectin Therapeutics Inc. (NASDAQ:GALT): Targeting Galectin-3 to Treat Liver Fibrosis and Cancer
Published on September 24, 2024